Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Mar 6;74(7):109-115.
doi: 10.15585/mmwr.mm7407a1.

Idiopathic Pulmonary Fibrosis Mortality by Industry and Occupation - United States, 2020-2022

Affiliations

Idiopathic Pulmonary Fibrosis Mortality by Industry and Occupation - United States, 2020-2022

Jacek M Mazurek et al. MMWR Morb Mortal Wkly Rep. .

Abstract

Idiopathic pulmonary fibrosis (IPF), a progressive lung disease characterized by scarring and worsening lung function, has a poor prognosis. A recent systematic review estimated that 21% of IPF deaths might be attributable to occupational exposures. To describe IPF mortality among U.S. residents aged ≥15 years who were ever employed, by industry and occupation, CDC conducted an exploratory analysis of 2020-2022 multiple cause-of-death data. During 2020-2022, a total of 67,843 (39,712 [59%] male and 28,131 [41%] female) decedents had IPF, suggesting that during this 3-year period, 8,340 IPF deaths in males and 5,908 deaths in females might have been associated with occupational exposures. By industry group, the highest proportionate mortality ratios among males were among those employed in utilities (1.15) and among females, were among those employed in public administration (1.12). By occupation group, the highest IPF mortality rates among males were among community and social services workers (1.23) and among females among farming, fishing, and forestry workers (1.24). Estimates of elevated IPF mortality among workers in specific industries and occupations warrant confirmation, control of known exposure-related risk factors, and continued surveillance to better understand the full range of occupational exposures that might increase risk for developing IPF.

PubMed Disclaimer

Conflict of interest statement

All authors have completed and submitted the International Committee of Medical Journal Editors form for disclosure of potential conflicts of interest. No potential conflicts of interest were disclosed.

References

    1. Raghu G, Collard HR, Egan JJ, et al.; ATS/ERS/JRS/ALAT Committee on Idiopathic Pulmonary Fibrosis. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 2011;183:788–824. 10.1164/rccm.2009-040GL - DOI - PMC - PubMed
    1. Spagnolo P, Sverzellati N, Rossi G, et al. Idiopathic pulmonary fibrosis: an update. Ann Med 2015;47:15–27. 10.3109/07853890.2014.982165 - DOI - PubMed
    1. Jeganathan N, Smith RA, Sathananthan M. Mortality trends of idiopathic pulmonary fibrosis in the United States from 2004 through 2017. Chest 2021;159:228–38. 10.1016/j.chest.2020.08.016 - DOI - PubMed
    1. Papiris SA, Kannengiesser C, Borie R, et al. Genetics in idiopathic pulmonary fibrosis: a clinical perspective. Diagnostics (Basel) 2022;12:2928. 10.3390/diagnostics12122928 - DOI - PMC - PubMed
    1. Pauchet A, Chaussavoine A, Pairon JC, et al. Idiopathic pulmonary fibrosis: what do we know about the role of occupational and environmental determinants? A systematic literature review and meta-analysis. J Toxicol Environ Health B Crit Rev 2022;25:372–92. 10.1080/10937404.2022.2131663 - DOI - PubMed